Serum IL-33 Levels Are Associated with Liver Damage in Patients with Chronic Hepatitis C
Figure 1
The levels of serum IL-33. The concentrations of serum IL-33 in individual CHC patients, those with SR-HCV and HC, and the levels of serum ALT and AST were determined by ELISA and automatic enzymatic assays, respectively. The potential association of the levels of serum IL-33, ALT, and AST was analyzed using the Spearman rank correlation test. Data are expressed as the mean values of individual participants from two separate experiments. The horizontal lines indicate the median values of different groups. (a) The basal levels of serum IL-33; (b) the levels of serum IL-33 in those with different levels of serum ALT; (c) the levels of serum IL-33 in those with different levels of serum AST; (d) the correlation between the levels of serum IL-33 and ALT; (e) the correlation between the levels of serum IL-33 and AST. HC: healthy controls; CHC: patients with CHC; SR-HCV: individual with spontaneously resolved HCV patients (SR-HCV).
